Overlapping syndrome with Familial Partial Lipodystrophy, Dunnigan variety and Cardiomyopathy due to Amino-terminal Heterozygous Missense lamin A/C Mutations

Documenti analoghi

• Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety
  di: Simha, Vinaya, et al.
  Pubblicazione: (2012)
• Novel Heterozygous LMNA Variants Causing Familial Partial Lipodystrophy, Dunnigan Variety
  di: Wadhwa, Akhilesh, et al.
  Pubblicazione: (2021)
• Mutational and Haplotype Analyses of Families with Familial Partial Lipodystrophy (Dunnigan Variety) Reveal Recurrent Missense Mutations in the Globular C-Terminal Domain of Lamin A/C
  di: Speckman, Rebecca A., et al.
  Pubblicazione: (2000)
• Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety
  di: Vasandani, Chandna, et al.
  Pubblicazione: (2020)
• Increased Skeletal Muscle Volume in Women With Familial Partial Lipodystrophy, Dunnigan Variety
  di: Ji, Hongzhao, et al.
  Pubblicazione: (2013)